Articles with "compared clopidogrel" as a keyword



Photo by cravethebenefits from unsplash

Pharmacokinetics and pharmacokinetic/pharmacodynamic relationship of vicagrel, a novel thienopyridine P2Y12 inhibitor, compared with clopidogrel in healthy Chinese subjects following single oral dosing

Sign Up to like & get
recommendations!
Published in 2019 at "European Journal of Pharmaceutical Sciences"

DOI: 10.1016/j.ejps.2018.10.011

Abstract: Background and objectives Vicagrel, a novel thienopyridine antiplatelet agent, is an analogue of clopidogrel in development for the treatment of acute coronary syndromes. This study investigated the pharmacokinetic properties of vicagrel after single oral dosing… read more here.

Keywords: healthy chinese; clopidogrel; vicagrel; compared clopidogrel ... See more keywords
Photo from wikipedia

Ticagrelor attenuates the increase of extracellular vesicle concentrations in plasma after acute myocardial infarction compared to clopidogrel

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of Thrombosis and Haemostasis"

DOI: 10.1111/jth.14689

Abstract: Platelet P2Y12 antagonist ticagrelor reduces mortality after acute myocardial infarction (AMI) compared to clopidogrel, but the underlying mechanism is unknown. Because activated platelets, leukocytes, and endothelial cells release proinflammatory and prothrombotic extracellular vesicles (EVs), we… read more here.

Keywords: ticagrelor; compared clopidogrel; myocardial infarction; acute myocardial ... See more keywords
Photo from wikipedia

Effect of Ticagrelor on Coronary Blood Flow and Prognosis in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention in Real World

Sign Up to like & get
recommendations!
Published in 2018 at "Chinese Medical Journal"

DOI: 10.4103/0366-6999.244106

Abstract: To the Editor: Current treatment guidelines for patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) recommend dual antiplatelet therapy, a combination of aspirin and a P2Y12 inhibitor (i.e., clopidogrel, prasugrel, and ticagrelor)… read more here.

Keywords: ticagrelor; patients acute; compared clopidogrel; percutaneous coronary ... See more keywords